Reported 72,217 shares, unchanged from the prior quarter.
Reported value -12.2%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 301000 |
| 2021-12-31 | 164000 |
| 2022-03-31 | 201000 |
| 2022-06-30 | 160000 |
| 2022-09-30 | 129000 |
| 2022-12-31 | 144434 |
| 2023-03-31 | 113381 |
| 2023-06-30 | 49830 |
| 2023-09-30 | 43330 |
| 2023-12-31 | 77446 |
| 2024-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2024 | Reduced | 0 | -144,434 (-100.0%) | 0 | $0 | 2024-05-09 | |
| Q4 2023 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $77,446 | 2024-02-07 | |
| Q3 2023 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $43,330 | 2023-11-06 | |
| Q2 2023 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $49,830 | 2023-08-08 | |
| Q1 2023 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $113,381 | 2023-05-02 | |
| Q4 2022 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $144,434 | 2023-02-06 | |
| Q3 2022 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $129,000 | 2022-11-04 | |
| Q2 2022 | Unchanged | 144,434 | 0 (0.0%) | < 0.01% | $160,000 | 2022-07-27 | |
| Q1 2022 | Added | 144,434 | +72,217 (100.0%) | < 0.01% | $201,000 | 2022-04-26 | |
| Q4 2021 | Unchanged | 72,217 | 0 (0.0%) | < 0.01% | $164,000 | 2022-01-31 | |
| Q3 2021 | Unchanged | 72,217 | 0 (0.0%) | < 0.01% | $301,000 | 2021-11-09 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
92 managers reported ONCTERNAL THERAPEUTICS INC COM for Q3 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Reduced | 3,199,191 | -538 | < 0.01% | $13,340,000 | 10 qtrs |
| VANGUARD GROUP INC | Added | 2,120,623 | +13,023 | < 0.01% | $8,844,000 | 10 qtrs |
| STATE STREET CORPORATION | Added | 807,637 | +76,446 | < 0.01% | $3,368,000 | 10 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 762,449 | +23,050 | < 0.01% | $3,179,000 | 10 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 569,032 | -20,613 | < 0.01% | $2,373,000 | 10 qtrs |
| MORGAN STANLEY | Added | 527,868 | +253,387 | < 0.01% | $2,201,000 | 10 qtrs |
| TWO SIGMA INVESTMENTS LP | Reduced | 452,471 | -100,271 | < 0.01% | $1,887,000 | 4 qtrs |
| ACT CAPITAL MANAGEMENT LLC | Unchanged | 360,000 | 0 | 0.78% | $1,501,000 | 2 qtrs |
| BRIGHTON JONES LLC | Added | 333,875 | +1,000 | 0.07% | $1,392,000 | 3 qtrs |
| Parkman Healthcare Partners LLC | Reduced | 325,384 | -90,000 | 0.34% | $1,357,000 | 4 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2021
- Filed
- November 09, 2021
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 72,217
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.